The type 1 insulin-like growth factor receptor pathway.

The type 1 insulin-like growth factor receptor pathway.

Research conducted over the past two decades has shown the importance of the type 1 insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to existing forms of cancer therapy. The IGF1R itself has only recently been accepted as a credible treatment target, however,...

Descripció completa

Dades bibliogràfiques
Autors principals:	Chitnis, M, Yuen, J, Protheroe, A, Pollak, M, Macaulay, V
Format:	Journal article
Idioma:	English
Publicat:	2008

Ítems similars

Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.
per: Aleksic, T, et al.
Publicat: (2010)

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer.
per: Yuen, J, et al.
Publicat: (2009)

Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
per: Yuen, J, et al.
Publicat: (2009)

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer.
per: Yuen, J, et al.
Publicat: (2008)

The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.
per: Rochester, M, et al.
Publicat: (2007)

Type 1 insulin-like growth factor receptor inhibition as treatment for urological cancer
per: Chitnis, M, et al.
Publicat: (2013)

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
per: Bohula, E, et al.
Publicat: (2003)

Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
per: Macaulay, V, et al.
Publicat: (2016)

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor.
per: Hellawell, G, et al.
Publicat: (2003)

Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
per: Brierley, G, et al.
Publicat: (2010)

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
per: Hellawell, G, et al.
Publicat: (2002)

Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase.
per: Macaulay, V, et al.
Publicat: (2001)

How ligand binds to the type 1 insulin-like growth factor receptor
per: Yibin Xu, et al.
Publicat: (2018-02-01)

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors.
per: Macaulay, V, et al.
Publicat: (2013)

The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript.
per: Bohula, E, et al.
Publicat: (2003)

Insulin like growth factor receptor 1 (IGF-1R) and radiotherapy resistance in laryngeal squamous cell cancer (LSCC)
per: Qureishi, A, et al.
Publicat: (2018)

Structural basis of the activation of type 1 insulin-like growth factor receptor
per: Jie Li, et al.
Publicat: (2019-10-01)

Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin.
per: Playford, M, et al.
Publicat: (2000)

The insulin-like growth factor system as a therapeutic target in colorectal cancer.
per: Hassan, A, et al.
Publicat: (2002)

Type I Insulin-like Growth Factor Receptor Induces Pulmonary Tumorigenesis
per: Nicolle M. Linnerth, et al.
Publicat: (2009-07-01)

Insulin-Like Growth Factor Pathway and the Thyroid
per: Terry J. Smith
Publicat: (2021-06-01)

Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection
per: Ammaji Rajala, et al.
Publicat: (2022-07-01)

Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy
per: Duo Zhang, et al.
Publicat: (2015-01-01)

Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks
per: Turney, B, et al.
Publicat: (2012)

Activation of the insulin receptor by insulin-like growth factor 2
per: Weidong An, et al.
Publicat: (2024-03-01)

Insulin-Like Growth Factor Binding Protein-6 Promotes the Differentiation of Placental Mesenchymal Stem Cells into Skeletal Muscle Independent of Insulin-Like Growth Factor Receptor-1 and Insulin Receptor
per: Doaa Aboalola, et al.
Publicat: (2019-01-01)

Protegrin 1 Enhances Innate Cellular Defense via the Insulin-Like Growth Factor 1 Receptor Pathway
per: Jenna Penney, et al.
Publicat: (2018-09-01)

Lectin-induced alterations of the interaction of insulin and insulin-like growth factor 1 receptors with their ligands
per: ROMANA MASNIKOSA, et al.
Publicat: (2008-08-01)

Insulin-like growth factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies
per: Simpson, A, et al.
Publicat: (2017)

Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls
per: Mary Jo Fidler, et al.
Publicat: (2012-03-01)

Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition
per: Jennifer A. Hurcombe, et al.
Publicat: (2024-05-01)

Imprinted Grb10, encoding growth factor receptor bound protein 10, regulates fetal growth independently of the insulin-like growth factor type 1 receptor (Igf1r) and insulin receptor (Insr) genes
per: Kim Moorwood, et al.
Publicat: (2024-05-01)

Type 1 insulin-like growth factor receptor (IGF-1R) targeted therapies in pediatric cancer
per: Michael J Wagner, et al.
Publicat: (2013-02-01)

Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
per: Dora Maria Cedano Prieto, et al.
Publicat: (2017-01-01)

Targeting the insulin-like growth factor-1 receptor in human cancer
per: Alexandre eArcaro
Publicat: (2013-03-01)

Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.
per: Macaulay, V, et al.
Publicat: (2010)

Type 1 insulin-like growth factor signalling in malignant melanoma
per: Goodfellow, M, et al.
Publicat: (2012)

Insulin-like growth factors: Ligands, binding proteins, and receptors
per: Derek LeRoith, et al.
Publicat: (2021-10-01)

Gastrodin Exerts Cardioprotective Action via Inhibition of Insulin-Like Growth Factor Type 2/Insulin-Like Growth Factor Type 2 Receptor Expression in Cardiac Hypertrophy
per: Jun Lu, et al.
Publicat: (2021-06-01)

Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
per: Kola, B, et al.
Publicat: (2003)